Psoriatic Arthritis Journal Articles
- Safety of IV Golimumab in RA, PsA, and AS
- Drug Dosing in Hospitalized Obese Patients With COVID-19
- Response Time for Outcomes in Psoriatic Arthritis Treatment
- Predictive Diagnostic Criteria for Psoriasis in Children
- Janus Kinase and Tyrosine Kinase Inhibitors in Dermatology
- Rheumatic Disease Flare-Up After SARS-CoV-2 mRNA Vaccine
- Safety and Efficacy of Tofacitinib for Ulcerative Colitis
- Psoriasis-related Treatment, Hospitalization Due to COVID-19
- Association of Sex and Systemic Therapy Outcomes in Psoriasis
- Secukinumab vs. Adalimumab in Psoriatic Arthritis and Psoriasis
- Patient Pathways to Diagnosis of Psoriatic Arthritis
- Malignancy Risk in Patients With Secukinumab-treated Psoriasis
- Secukinumab as a Potential Trigger of IBD in AS or PsA
- The Promise and Challenges of Cell Therapy for Psoriasis
- Interpreting Cortisol and SSTs to Prevent Misdiagnosis of AI
- Immune Checkpoint Inhibitor Treatment Toxicity Risk in RA
- Ustekinumab Maintenance Therapy in Ulcerative Colitis
- Mediterranean Diet in Axial Spondyloarthritis
- Cardiovascular Safety of Biologics Targeting IL-12 or IL-23
- Does Methotrexate Influence Covid-19 Infection?